Seven treatments are sold as “non-surgical facelifts.” I have ranked them from worst to best value — and one of the most popular is near the bottom.
Not because it never works. Because the improvement often fails to justify the price, the risk and the recovery.
Let me start with the uncomfortable part. A non-surgical facelift is not a facelift. No cream, needle or energy device reproduces the tissue repositioning of surgery. What the right treatment can do is improve early laxity, facial contour, skin quality or volume loss.
Those are four different problems. The beauty industry calls all of them “lifting.” That single piece of vocabulary is responsible for an enormous amount of wasted money.
How I am ranking these
This is not a universal ranking for every face. I am ranking for a typical patient with mild to moderate facial ageing who wants visible improvement without surgery, and I am weighing five things:
- How visible is the improvement?
- How long might it last?
- How much downtime is involved?
- What are the risks?
- Does it address the patient’s actual problem — or simply make the face look fuller?
Price varies enormously between countries, clinics and devices, so I am ranking relative value rather than quoting figures.
And before any treatment is chosen, something has to be identified: what is creating the appearance of ageing? Loose skin? Loss of facial fat or bone support? Changes in skin quality? Downward muscle pull? Treat the wrong layer and even a technically successful procedure produces the wrong face.
Seven. “Facelift” creams, tapes and gadgets
A moisturiser can temporarily plump the outer layers of skin. A film-forming product can create a temporary tightening sensation. Facial tape repositions skin while it is attached. Massage may briefly reduce puffiness.
None of it permanently repositions descended facial tissue.
If a cream could contract your deeper facial support structures, it would not be sitting casually next to the hand lotion. It would be regulated rather differently.
Use skincare for what skincare does well — hydration, pigmentation, acne, fine surface lines, and prevention of further photodamage. But if you have visible jowls or descended facial fat, no moisturiser will negotiate those tissues back into position.
Visible lift: minimal or temporary · Downtime: none · Value: poor when sold as a facelift
Six. Thread lifts
This one is controversial.
A thread lift places absorbable sutures beneath the skin to mechanically reposition tissue. In the correct patient, it can produce an immediate visible improvement. The crucial phrase is “the correct patient” — relatively mild laxity, suitable tissue weight, realistic expectations. Threads are far less convincing when the face is heavy, laxity is advanced, or the patient is expecting a surgical result.
A 2024 systematic review of 12 studies and 818 patients found that immediate aesthetic scores improved and dangerous complications were uncommon — but long-term efficacy data were limited, with the longest follow-up reaching two years. (Zhang LX et al. Dermatol Surg. 2024. PMID: 39662017.)
A separate systematic review documented complications including swelling, bruising, dimpling, thread visibility or palpability, infection, asymmetry, extrusion and sensory changes. Many are temporary or treatable — but they count when you are assessing value. (Pham CT et al. Dermatol Surg. 2021;47(11):1460–1465.)
My objection is not that threads never work. It is the relationship between result, longevity, cost and procedural burden. The immediate photographs can be impressive, but some of that early improvement may reflect swelling and mechanical tension. The more useful question is how the face looks months later.
Threads occupy an awkward middle ground: more invasive than an external energy device, less powerful and predictable than surgery, and heavily dependent on patient selection and operator technique. Worthwhile for a narrow group. Poor value when sold as a miniature facelift for everyone.
Visible lift: immediate but variable · Downtime: moderate · Value: highly patient-dependent
Five. The filler-only “liquid facelift”
Dermal filler is excellent at replacing or redistributing volume. It can support a flattened cheek, improve certain shadows, strengthen a chin, restore proportion.
But volume loss and tissue laxity are not the same problem. If the primary issue is sagging and we keep adding filler to lift it, the face becomes larger without becoming younger. The patient asks for less heaviness and leaves with more face.
Strategic structural placement can improve contour and may reduce the appearance of mild descent. But there is a limit. Filler does not excise loose skin. It does not reposition the SMAS. It does not reverse every form of facial ageing simply because enough syringes were used.
It also carries genuine medical risk — nodules, infection, vascular occlusion. Rare vascular events can cause tissue injury and, in exceptional cases, visual loss.
The best filler treatments are the ones where nobody thinks “that is excellent filler.” They simply think “you look well.”
Volume restoration: good · True tissue lift: limited · Value: good only when volume loss is the problem
Four. The botulinum toxin “lift”
Botulinum toxin relaxes muscles that pull certain facial areas downward. Careful treatment may produce a subtle brow elevation, a softer downward pull at the corners of the mouth, improved platysmal bands, or slightly cleaner jawline definition in a suitable patient.
“Subtle” is doing important work in that sentence.
A 2022 systematic review of micro-botulinum-toxin techniques included 372 patients. Doses, injection sites and definitions of lifting varied widely, and patient and physician assessments were highly discordant — which prevented a reliable objective estimate of the lifting effect. (Ng ZY, Lellouch AG. Dermatol Surg. 2022;48(8):849–854.)
Botulinum toxin is very effective when dynamic muscle activity is the actual problem, and much less impressive when loose skin or volume loss is the problem. Lower-face injections require a strong understanding of anatomy; an inappropriate dose or placement can affect the smile, lip movement or expression.
It ranks above filler-only lifting because it is targeted, temporary, and genuinely good value for a specific muscular problem. But it is a contouring adjustment, not a facelift hiding inside a small syringe.
Visible lift: subtle and anatomy-dependent · Downtime: minimal · Value: good for the right muscular problem
Three. Injectable biostimulators
This category includes products based on substances such as poly-L-lactic acid and calcium hydroxylapatite, which provide varying combinations of volume, structural support and stimulation of extracellular-matrix remodelling.
To be precise: a biostimulator is not a surgical lift. Its value is gradual improvement in skin quality, contour or volume — not pulling a significantly descended face upward.
A 2024 systematic review of 13 controlled trials of calcium hydroxylapatite reported improvements in global aesthetic assessment, facial wrinkles and satisfaction. The studies were heterogeneous in treatment areas and comparison groups, and several authors reported industry affiliations — which readers deserve to know. (Eghbali M et al. J Clin Med. 2024;13(6):1686.)
It ranks relatively highly because, in the correct patient, we are not pretending to perform a dramatic lift. We are improving the quality and support of ageing tissue gradually, and the result often looks more natural than repeatedly adding conventional filler to chase laxity.
But formulation, dilution, placement and patient selection all matter. Adverse effects include inflammation, nodules, infection and vascular complications, and some products are difficult or impossible to dissolve immediately, unlike hyaluronic acid filler.
So “stimulates your own collagen” should never be translated as “natural, therefore risk-free.” Fibrosis is also your own collagen. Biology is particular about where and how much it would like.
Skin quality and support: good · True lift: modest · Value: good for gradual, natural-looking improvement
Two. Radiofrequency
This covers monopolar and bipolar external radiofrequency devices as well as radiofrequency microneedling — which are not identical treatments. External radiofrequency delivers controlled heat without inserting needles; RF microneedling uses needles to deliver energy at selected depths. The aim in both cases is controlled thermal injury followed by remodelling.
A systematic review of 23 studies concluded that monopolar and bipolar radiofrequency devices produced measurable improvement in facial and body skin laxity with an acceptable complication profile. (Dayan E et al. Plast Reconstr Surg. 2022;150(4):771–780.)
A more recent systematic review of RF microneedling — 20 studies, 558 participants — reported improvements in texture and tightening, with redness and swelling the most common adverse effects. Several authors were affiliated with a device manufacturer, and the evidence spanned different devices, protocols and outcome measures. That limitation should not be hidden behind an impressive abstract. (Kumar N et al. J Cosmet Dermatol. 2026;25(4).)
Radiofrequency earns second place because it can address early laxity and texture without adding facial volume. But results depend heavily on the device, the temperature achieved, the depth of treatment, the number of passes, and the person operating it. Too little energy produces very little. Too much, at an inappropriate depth, can cause burns, pigmentary change, scarring or unwanted fat injury.
“A little heat” and “controlled medical energy” are not the same thing. And a home radiofrequency gadget is not equivalent to a clinic device simply because both become warm.
Visible lift: mild to moderate · Texture benefit: good · Value: strong with the right device and patient
One. Microfocused ultrasound — in the right patient
My number one for value, used for the correct indication.
You may also see the terms MFU, MFU-V or HIFU. These labels cover different devices and imaging capabilities and should not automatically be treated as equivalent. The treatment uses focused ultrasound energy to create small thermal coagulation zones at selected depths, and it suits mild to moderate laxity in someone who wants gradual improvement with little surface downtime.
Here is the part the marketing tends to omit. A 2023 systematic review of 16 studies found reported brow elevation ranging from approximately 0.47 to 1.7 millimetres. Investigator assessments frequently reported improvement, but patient-reported improvement was more modest — 42% at 90 days and 53% at one year in the pooled data available. Longer-term follow-up was lacking. (Contini M et al. Int J Environ Res Public Health. 2023;20(2):1522.)
This is exactly why I rank it highly and dislike the advertising. The evidence supports modest tightening. Not a facelift. Not five centimetres of lift. Millimetres.
For the right patient those millimetres create a worthwhile improvement in brow position, jawline definition or submental contour. For someone with advanced jowling or a heavy face, the same treatment may disappoint — the review found outcomes declined with greater laxity and higher body mass index. Treatment was moderately painful, and reported adverse effects included temporary redness and swelling, with less common effects including altered sensation, bruising and burns.
If a clinic promises a surgical result, the problem is not necessarily the ultrasound. It is the adjective department.
Visible lift: modest but measurable · Downtime: low · Value: best for carefully selected mild-to-moderate laxity
The ranking changes when the diagnosis changes
The final order, from worst to best value:
- Facelift creams, tapes and gadgets
- Thread lifts
- Filler-only liquid facelifts
- Botulinum toxin lifting
- Injectable biostimulators
- Radiofrequency
- Microfocused ultrasound, for the correctly selected patient
But this list moves the moment the diagnosis moves.
If your main problem is volume loss, a small amount of carefully placed filler may offer better value than ultrasound. If the problem is platysmal pull, botulinum toxin is the smarter treatment. If the problem is poor skin quality, a biostimulator or radiofrequency may be more appropriate. And if the problem is significant tissue descent, none of these may offer good value at all.
Repeating modest treatments in pursuit of a surgical result can eventually cost more than surgery — while still not producing surgery.
Sometimes the most ethical non-surgical recommendation is: do not spend your money on a non-surgical treatment.
What I would actually choose
For early ageing, the best value is rarely one large treatment. It is a restrained plan.
Protect the skin from UV damage. Maintain skin quality. Treat muscle pull only where it contributes to the problem. Restore volume only where volume has genuinely been lost. Use an energy device only when the type and degree of laxity make it appropriate.
Combination treatment does not mean doing everything. It means treating different anatomical problems with the smallest effective intervention.
The goal is not to make a 50-year-old face look 25. It is to make the face look rested, balanced and recognisably yours. If your family can identify the exact date you visited the clinic, subtlety may have left the building.
Four questions worth asking
Before any treatment sold as a lift:
- What layer is being treated?
- How will the result be measured?
- How long does the evidence follow patients?
- What can this treatment not do?
A trustworthy practitioner should be able to answer all four without reaching for a brochure.
Listen to the full episode of The Chai Files:
Non-Surgical Facelift Options Ranked: From Worst to Best Value
This article is for general education and does not replace an individual medical consultation. Treatment suitability, regulatory status and risks vary according to the patient, product, device and country.
